Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 1,188.10
-52.50 (-4.23%)
Nov 4, 2026, 3:29 PM IST
Zydus Lifesciences Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 303,781 | 271,484 | 232,415 | 195,474 | 172,374 | 151,099 |
Revenue Growth | 24.02% | 16.81% | 18.90% | 13.40% | 14.08% | 4.90% |
Gross Profit Gross Profit Growth | 219,403 | 196,248 | 167,031 | 131,537 | 107,667 | 94,242 |
Operating Income Operating Income Growth | 52,261 | 58,249 | 59,602 | 45,392 | 28,528 | 24,741 |
Net Income Net Income Growth | 41,982 | 50,400 | 45,255 | 38,595 | 19,603 | 44,873 |
Earnings Per Share EPS Growth | 41.83 | 50.09 | 44.97 | 38.14 | 19.30 | 43.83 |
EPS Growth | -14.45% | 11.37% | 17.92% | 97.61% | -55.97% | 110.32% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Pharmaceuticals (excl. Medical Technologies) Pharmaceuticals (excl. Medical Technologies) Growth | 229,960 | 224,121 | 205,415 | - | - | - |
Consumer Products Consumer Products Growth | 45,324 | 39,540 | 26,976 | 23,120 | 22,448 | 19,788 |
Medical Technologies Medical Technologies Growth | 10,633 | 7,823 | 24 | - | - | - |
Total Total Growth | 285,917 | 271,484 | 232,415 | 195,474 | 172,374 | 151,099 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 52,159 | 49,711 | 56,416 | 13,530 | 11,924 | 39,735 |
Total Debt Total Debt Growth | 139,664 | 125,146 | 32,180 | 8,219 | 11,951 | 42,210 |
Net Cash (Debt) Net Cash Growth | -87,505 | -75,435 | 24,236 | 5,311 | -27 | -2,475 |
Net Cash Growth | - | - | 356.34% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -87.19 | -74.97 | 24.09 | 5.25 | -0.03 | -2.42 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 40,582 | 21,166 | 67,811 | 31,963 | 26,888 | 21,045 |
Capital Expenditures CapEx Growth | -37,877 | -33,940 | -16,937 | -9,066 | -10,309 | -12,026 |
Free Cash Flow Free Cash Flow Growth | 2,705 | -12,774 | 50,874 | 22,897 | 16,579 | 9,019 |
Free Cash Flow Growth | -89.34% | - | 122.19% | 38.11% | 83.82% | -63.03% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 72.22% | 72.29% | 71.87% | 67.29% | 62.46% | 62.37% |
Operating Margin | 17.20% | 21.46% | 25.64% | 23.22% | 16.55% | 16.37% |
Pretax Margin | 18.76% | 24.75% | 26.18% | 25.21% | 15.57% | 19.09% |
Profit Margin | 13.82% | 18.57% | 19.47% | 19.74% | 11.37% | 29.70% |
FCF Margin | 0.89% | -4.71% | 21.89% | 11.71% | 9.62% | 5.97% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 4, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.000 | 1.000 | 11.000 | 3.000 | 6.000 | 2.500 |
Dividend Per Share Growth | -90.91% | -90.91% | 266.67% | -50.00% | 140.00% | -28.57% |
Dividend Yield | 0.08% | 0.11% | 1.24% | 0.30% | 1.22% | 0.72% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 4, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 28.40 | 17.39 | 19.71 | 26.26 | 25.38 | 7.95 |
Forward PE | 26.34 | 20.54 | 19.01 | 28.46 | 21.39 | 16.57 |
P/FCF Ratio | 438.13 | - | 17.53 | 44.27 | 30.01 | 39.56 |
PS Ratio | 3.90 | 3.23 | 3.84 | 5.19 | 2.89 | 2.36 |